Quotient Bioresearch acquires radiochemical custom synthesis operations from GE Healthcare
Major investment in new radiochemicals facility to be located in Cardiff, Wales
30-Jun-2009 -
Quotient Bioresearch Limited announced that it has reached an agreement to acquire Amersham Radiolabelling Services, the radiochemical custom synthesis operations of GE Healthcare. This represents Quotient’s seventh acquisition since its formation in early 2007.
According to the company, this ...
Amersham
biotechnology
contract synthesis
+4